ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2181

Natural Disease Progression in Hand Osteoarthritis: Results from a Belgian Ten-years Prospective Cohort Study

Lisa Pardaens 1, Tine Vanhaverbeke 1, Jordy Vandercruyssen 1 and Ruth Wittoek2, 1Ghent University, Gent, Belgium, 2Ghent University Hospital, Gent University, Gent, Belgium

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: hand and radiography, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Limited evidence is available about natural disease progression in hand osteoarthritis (HOA).  A previous study of the Ghent HOA cohort showed a positive association between soft tissue swelling, tenderness upon pressure and pain with radiographic progression (1). The aim of the study is to study natural radiographic and clinical disease progression in HOA after 10 years of follow up.

Methods: From 2007 to 2009 (baseline, T0), 270 patients with HOA were included in a Belgian HOA register. On average, the disease was already ongoing for > 12 years at baseline. A first follow up visit (T1) occurred after approximately 5 years (n = 154) and a 2nd (T2) after 10 years (n= 106). Presence of tender and swollen joints was assessed. Grip strength was measured. FIHOA and AUSCAN were completed. Pain was scored on visual analogue scale (VAS pain, 0 -100). Radiographs of hands were taken and scored according to the scoring system by Verbruggen and Veys (2). Patients were categorized into ‘non-significant radiographic progression’, ‘erosive (‘E’) progression only’, ‘‘E’  progression and remodeling (‘R’) occurring simultaneously’ and ‘‘R’ progression only’. Changes from N to S were considered non relevant. Longitudinal analyses were performed for patient related outcome measures from follow up (T1 or T2) to baseline (T0).

Results: After a mean follow-up of 9.7 years at T2, the majority of the patients (73.3%) showed any radiographic progression compared to baseline (figure 1). Exclusive ‘E’ progression is rare (0.6% from T1 to T0, and 1.1% from T2 to T1). Any ‘E and R progression’ is seen in 11% and 14.1%, resp. from T1 to T0, and T2 to T1. ‘R’ progression only is seen more often from T1 to T0 (61.1%) compared to T2 to T1 (39.2%)(p< 0.05). FIHOA and AUSCAN, increased numerically over time and statistically significant after visit T2 (p = 0.035 for AUSCAN and p = 0.017 for FIHOA) (figure 2). Pain (measured by VAS and AUSCAN pain subscale) did not consistently nor significantly change over time (figure 3).After a mean follow-up of 9.7 years at T2, the majority of the patients (73.3%) showed any radiographic progression compared to baseline (figure 1). Exclusive ‘E’ progression is rare (0.6% from  T1 to T0, and 1.1% from T2 to T1). Any ‘E and R progression’ is seen in 11% and 14.1%, resp. from T1 to T0, and T2 to T1. ‘R’ progression only is seen more often from T1 to T0 (61.1%) compared to T2 to T1 (39.2%)(p< 0.05). FIHOA and AUSCAN, increased numerically over time and statistically significant after visit T2 (p = 0.035 for AUSCAN and p = 0017 for FIHOA) (figure 2). Pain (measured by VAS and AUSCAN pain subscale) did not consistently nor significantly change over time (figure 3).

Conclusion: HOA is a disease where significant radiographic progression is seen over time, with erosive progression being relatively rare and remodeling occurring frequently. While levels of pain remain similar over time, functional status does decrease. Future treatment goals in HOA should focus on preserving the functional status of HOA patients. Research is required to confirm this pattern of disease progression in a ‘early’ HOA cohort and amongst several subtypes of HOA.

References
1. Meersseman P, et al. OAC 2015;23(12):2129-33.
2. Verbruggen G and Veys EM. A&R 1996;39(2):308-20.


figure 1

Radiographic progression in HOA from baseline to T1 and T1 to T2


Figure 2

Longitudinal changes in functional status -FIHOA and AUSCAN function-


Figure 3

Longitudinal changes in pain -VAS pain and AUSCAN pain-


Disclosure: L. Pardaens, None; T. Vanhaverbeke, None; J. Vandercruyssen, None; R. Wittoek, None.

To cite this abstract in AMA style:

Pardaens L, Vanhaverbeke T, Vandercruyssen J, Wittoek R. Natural Disease Progression in Hand Osteoarthritis: Results from a Belgian Ten-years Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/natural-disease-progression-in-hand-osteoarthritis-results-from-a-belgian-ten-years-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/natural-disease-progression-in-hand-osteoarthritis-results-from-a-belgian-ten-years-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology